首页> 美国卫生研究院文献>Diabetes Care >Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes

【2h】

Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes

机译：与1型糖尿病患者相比新型长效基础胰岛素LY2605541与甘精胰岛素相比具有更好的血糖控制和减肥效果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVETo compare effects of LY2605541 versus insulin glargine on daily mean blood glucose as part of a basal-bolus regimen for type 1 diabetes.

机译：目的比较LY2605541和甘精胰岛素对1型糖尿病基础推注方案每日平均血糖的影响。

著录项

期刊名称 Diabetes Care
作者
Julio Rosenstock; Richard M. Bergenstal; Thomas C. Blevins; Linda A. Morrow; Melvin J. Prince; Yongming Qu; Vikram P. Sinha; Daniel C. Howey; Scott J. Jacober;
展开▼
作者单位

展开▼
年(卷),期 2013(36),3
年度 2013
页码 522–528
总页数 7
原文格式 PDF
正文语种
中图分类护理学;
关键词

相似文献

外文文献
中文文献
专利

1. Better glycemic control and weight loss with thenovel long-acting basal insulin ly2605541 compared with insulin glargine in type 1 diabetes [J] . RosenstockJ., BergenstalR.M., BlevinsT.C., Diabetes care . 2013,第3期

机译：与甘精胰岛素相比，novel长效基础胰岛素ly2605541可以更好地控制血糖和减轻体重
2. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes [J] . Bergenstal,R.M., Rosenstock,J., Arakaki,R.F., Diabetes care . 2012,第11期

机译：每日一次的新型长效基础胰岛素LY2605541与甘精胰岛素对基础胰岛素治疗的2型糖尿病患者的随机对照研究
3. INSULIN GLARGINE 300 U/ML IS ASSOCIATED WITH LESS WEIGHT GAIN WHILE MAINTAINING GLYCEMIC CONTROL AND LOW RISK OF HYPOGLYCEMIA COMPARED WITH INSULIN GLARGINE 100 U/ML IN AN AGING POPULATION WITH TYPE 2 DIABETES [J] . Munshi Medha N., Gill Jasvinder, Chao Jason, Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists . 2018,第2期

机译：胰岛素冰柱300u / ml与体重减轻较小，同时保持血糖控制和低血糖的低风险与患有2型糖尿病的老化人群中的胰岛素龟甲100 u / ml相比
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. The relationship between the emotional burden of Type 2 Diabetes and glycemic control and differences in emotional burden and glycemic control among individuals treated with oral antidiabetic agents, combination therapy, incretin mimetic, and insulin [D] . Douaihy, Katharine 2008

机译：2型糖尿病患者的情绪负担与血糖控制之间的关系以及口服抗糖尿病药，联合疗法，降钙素模拟物和胰岛素治疗的个体之间情绪负担和血糖控制的差异
6. Response to Comment on: Bergenstal et al. A Randomized Controlled Study of Once-Daily LY2605541 a Novel Long-Acting Basal Insulin Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147 [O] . Richard M. Bergenstal, Julio Rosenstock, Richard F. Arakaki, 2013

机译：对评论的回应：Bergenstal等。每日一次LY2605541（一种新型的长效基础胰岛素）与基础胰岛素治疗的2型糖尿病患者的胰岛素甘精胰岛素的随机对照研究。糖尿病护理2012; 35：2140–2147
7. Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes: A randomized, crossover study [O] . J. Rosenstock, R. M. Bergenstal, T. C. Blevins, 2012

机译：具有新型长效基础胰岛素LY2605541的血糖控制和体重减轻与1型糖尿病患者的胰岛素冰壶：随机交叉研究

Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes

摘要

著录项

相似文献

相关主题

期刊订阅